Hong Xie
350005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Fluvastatin Upregulates the α 1C Subunit of CaV1.2 Channel Expression in Vascular Smooth Muscle Cells via RhoA and ERK/p38 MAPK Pathways".
Journal: Disease markers
Published: May 17, 2024
Honokiol ameliorates angiotensin II-induced cardiac hypertrophy by promoting dissociation of the Nur77-LKB1 complex and activating the AMPK pathway.
Journal: Journal of cellular and molecular medicine
Published: May 02, 2023
Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
Journal: Cardiovascular diabetology
Published: March 01, 2021
Retinoid X receptor agonists attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes through LKB1-dependent anti-fibrosis effects.
Journal: Clinical science (London, England : 1979)
Published: October 04, 2019
A meta-analytical comparison of atenolol with angiotensin-converting enzyme inhibitors on arterial stiffness, peripheral blood pressure and heart rate in hypertensive patients.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: May 24, 2017
Lowered circulating apelin is significantly associated with an increased risk for hypertension: A meta-analysis.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)
Published: May 24, 2017
Fluvastatin upregulates the α 1C subunit of CaV1.2 channel expression in vascular smooth muscle cells via RhoA and ERK/p38 MAPK pathways.
Journal: Disease markers
Published: October 24, 2014
Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.
Journal: American journal of hypertension
Published: March 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026